Moreover, CCN3 blockade in healthy MVECs resulted in the impairment of their migratory and angiogenic abilities, while treatment of SSc MVECs with recombinant human CCN3 significantly improved their in vitro angiogenesis [30]. Here, CCN3 is linked to systemic sclerosis.